NF-κB in immunobiology
NF-κB was first discovered and characterized 25 years ago as a key regulator of inducible
gene expression in the immune system. Thus, it is not surprising that the clearest biological …
gene expression in the immune system. Thus, it is not surprising that the clearest biological …
Activators and target genes of Rel/NF-κB transcription factors
HL Pahl - Oncogene, 1999 - nature.com
The vertebrate transcription factor NF-κB is induced by over 150 different stimuli. Active NF-
κB, in turn, participates in the control of transcription of over 150 target genes. Because a …
κB, in turn, participates in the control of transcription of over 150 target genes. Because a …
NF-κB and the immune response
One of the primary physiological roles of nuclear factor-kappa B (NF-κB) is in the immune
system. In particular, NF-κB family members control the transcription of cytokines and …
system. In particular, NF-κB family members control the transcription of cytokines and …
The proteasome: a suitable antineoplastic target
J Adams - Nature Reviews Cancer, 2004 - nature.com
The proteasome is an abundant multi-enzyme complex that provides the main pathway for
degradation of intracellular proteins in eukaryotic cells. As such, it controls the levels of …
degradation of intracellular proteins in eukaryotic cells. As such, it controls the levels of …
Control of apoptosis by Rel/NF-κB transcription factors
M Barkett, TD Gilmore - Oncogene, 1999 - nature.com
Apoptosis is a physiological process critical for organ development, tissue homeostasis, and
elimination of defective or potentially dangerous cells in complex organisms. Apoptosis can …
elimination of defective or potentially dangerous cells in complex organisms. Apoptosis can …
Development of the proteasome inhibitor Velcade™(Bortezomib)
J Adams, M Kauffman - Cancer investigation, 2004 - Taylor & Francis
The dipeptide boronic acid analogue VELCADE™(Bortezomib; formerly known as PS-341,
LDP-341 and MLM341) is a potent and selective inhibitor of the proteasome, a multicatalytic …
LDP-341 and MLM341) is a potent and selective inhibitor of the proteasome, a multicatalytic …
The proteasome: structure, function, and role in the cell
J Adams - Cancer treatment reviews, 2003 - Elsevier
The proteasome is a multisubunit enzyme complex that plays a central role in the regulation
of proteins that control cell-cycle progression and apoptosis, and has therefore become an …
of proteins that control cell-cycle progression and apoptosis, and has therefore become an …
The inhibitors of apoptosis (IAPs) and their emerging role in cancer
The inhibitor of apoptosis protein family has been characterized over the past 5 years,
initially in baculovirus and more recently in metazoans. The IAPs are a widely expressed …
initially in baculovirus and more recently in metazoans. The IAPs are a widely expressed …
Cellular stress response and apoptosis in cancer therapy
I Herr, KM Debatin - Blood, The Journal of the American Society …, 2001 - ashpublications.org
Anticancer treatment using cytotoxic drugs is considered to mediate cell death by activating
key elements of the apoptosis program and the cellular stress response. While proteolytic …
key elements of the apoptosis program and the cellular stress response. While proteolytic …
Death receptors in chemotherapy and cancer
KM Debatin, PH Krammer - Oncogene, 2004 - nature.com
Apoptosis, the cell's intrinsic death program, is a key regulator of tissue homeostasis. An
imbalance between cell death and proliferation may result in tumor formation. Also, killing of …
imbalance between cell death and proliferation may result in tumor formation. Also, killing of …